Access Menu

Log in via Social

Onko Solutions

Onko Solutions

We develop advanced and innovative solutions to detect and prevent cancer in underserved populations.

Austin, Texas, US

biotechnology, healthcare, pharmaceutical, women's health, health care, medical devices, social enterprise, healthcare innovation, international development, disruptive technology, diagnostics, biotech companies, life science, medical device, biotech cancer medical technology , healthcare technology, cancer screening, cancer prevention, cervical cancer, developing country, underdeveloped country

This company and others may be fundraising.

Login or signup to access deals.

Connect with Company

Company Overview

Onko Solutions, LLC is a company committed to the development and commercialization of innovative technology solutions that contribute to the detection, prevention and treatment of cancer in underserved populations.

We are dedicated to transforming lives with reliable solutions in the detection and treatment of cancer that offer immediate results and are affordable for everyone.

We are currently working in early cervical cancer detection. Mortality related to cervical cancer is rare among women who get screened regularly. However, only 40 to 50% of women in developed countries get screened every year, while in underdeveloped countries that number drops to an alarming 5%.

There is an urgent need for palpable, cost-effective, reproducible and non-invasive solutions that significantly reduce the fatalities attributed to cervical cancer. Such solutions are especially urgent in developing countries that lack the resources and equipment to perform cytodiagnosis.

Onko Solutions has developed a portable medical device for effective, reliable, fast and non-invasive screening for cervical cancer that unlike Pap smears, HPV tests, or biopsies, does not require laboratory analysis or a tissue sample, making it ideal and available to underprivileged regions.

Our device is designed to provide non-invasive screening with instantaneous results, eliminating costly, painful and unnecessary lab work.

KPIs

18,000 Users
$900,000 Sales
2 Issued Patents

Traction

Verbal Commitment from 2 institutional investors for another $650,000 USD investment pending a trial of 150 women in Guadalajara, MX.

July, 2015

Regulatory approval (TruScreen by Onko Solutions)

July, 2015

Sales begin in Mexico (TruScreen by Onko Solutions)

August, 2015

Complete product development of proprietary solution

November, 2015

Complete clinical trials of proprietary solution

December, 2015

Proprietary product receives approval to be marketed in Mexico

February, 2016

Sales begin in Mexico

April, 2016

Sales begin in Latin America

June, 2016

Technology feasibility testing for FDA approval

May, 2016

Present pre-submission package for FDA approval

August, 2016

Initiate clinical trials FDA/CE Mark

October, 2016

Testimonials

“This device will revolutionize the field of preventive health for women. It combines and eliminates everything that is stopping the Pap test from being a routine test for all the women in the world.”
Martin F. Gynecologist, Private Sector
Martin F.
"This method removes the taboo and psychological elements that keep many women away from a Pap test; elements that may also cause many to erroneously dismiss it as a non-essential test."
Guillermo A. Gynecologist, Private Sector
Guillermo A.
“The immediate results would make me feel calm and safe. This device makes the Pap test seem obsolete.”
Sarah C. Gynecologist, Private Sector
Sarah C.
“I believe this technology will take away the fear caused by a Pap test and eradicate the ache and discomfort that this test brings to so many of us.”
Sandra G. Patient
Sandra G.
Loading...